Literature DB >> 28214551

Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma.

Meryem Bouchemi1, Christophe Roubeix2, Karima Kessal2, Luisa Riancho2, Anne-Laure Raveu2, Hayet Soualmia3, Christophe Baudouin4, Françoise Brignole-Baudouin5.   

Abstract

PURPOSE: To validate a new culture model of primary human trabecular meshwork cells (p-hTMCs) using Matrigel®, in order to mimic in vitro 3D-TM organization, and to investigate the proinflammatory effect of benzalkonium chloride (BAK) in 3D p-hTMC cultures.
METHODS: p-hTMCs, seeded onto Matrigel®-coated inserts were stimulated with BAK (10-4%), dexamethasone (DEX) (10-6M) or transforming growth factor-beta 2 (TGF-β2) (5ng/ml) for 48h and observed with confocal microscopy. The BAK effect at 10-4% or 5.10-3% on the gene expressions of interleukin-6 (IL-6), interleukin-8 (IL-8) and matrix metalloproteinase (MMP-9) was investigated using qRT-PCR in 2D and 3D p-hTMC cultures.
RESULTS: p-hTMCs seeded in Matrigel® were able to organize themselves in a 3D-spatial conformation in the different conditions tested with cross-linked actin network (CLAN) formation in presence of DEX or TGF-β2 and intercellular space contraction with TGF-β2. IL-6 and IL-8 gene expressions increased in presence of BAK in 2D and in 3D p-hTMC cultures. BAK 10-4% only showed a tendency to stimulate MMP-9 expression in p-hTMCs after 24h-recovery.
CONCLUSIONS: We investigated this new 3D-TM in vitro model in Matrigel® matrix for pathophysiological and toxicological purposes. It appears as a new promising tool for a better understanding of TM behavior in physiological and stress conditions, as well as toxicological evaluations of antiglaucoma eyedrops and preservatives.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benzalkonium chloride; Interleukin-6; Interleukin-8; Matrigel®; Three-dimensional culture; Trabecular meshwork

Mesh:

Substances:

Year:  2017        PMID: 28214551     DOI: 10.1016/j.tiv.2017.02.006

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  13 in total

Review 1.  Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review.

Authors:  Raul E Ruiz-Lozano; Jimena Alamillo-Velazquez; Gustavo Ortiz-Morales; Lucas A Garza-Garza; Manuel E Quiroga-Garza; Carlos Alvarez-Guzman; Alejandro Rodriguez-Garcia
Journal:  Int Ophthalmol       Date:  2022-08-13       Impact factor: 2.029

2.  A Biomimetic, Stem Cell-Derived In Vitro Ocular Outflow Model.

Authors:  Yangzi Isabel Tian; Xulang Zhang; Karen Torrejon; John Danias; Yiqin Du; Yubing Xie
Journal:  Adv Biosyst       Date:  2020-07-30

Review 3.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

4.  Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis.

Authors:  Paul Harasymowycz; Cindy Hutnik; Jean-François Rouland; Francisco J Muñoz Negrete; Mario A Economou; Philippe Denis; Christophe Baudouin
Journal:  Adv Ther       Date:  2021-04-23       Impact factor: 3.845

Review 5.  Tissue-Engineered Models for Glaucoma Research.

Authors:  Renhao Lu; Paul A Soden; Esak Lee
Journal:  Micromachines (Basel)       Date:  2020-06-24       Impact factor: 2.891

6.  Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride.

Authors:  Anton G Rogov; Tatyana N Goleva; Evgeniya I Sukhanova; Khoren K Epremyan; Tatiana A Trendeleva; Alexandra P Ovchenkova; Dinara A Aliverdieva; Renata A Zvyagilskaya
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

7.  An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress.

Authors:  Stefania Vernazza; Sara Tirendi; Mario Passalacqua; Francesco Piacente; Sonia Scarfì; Francesco Oddone; Anna Maria Bassi
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

8.  The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma.

Authors:  Juliette Buffault; Françoise Brignole-Baudouin; Élodie Reboussin; Karima Kessal; Antoine Labbé; Stéphane Mélik Parsadaniantz; Christophe Baudouin
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

9.  Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension.

Authors:  David Wirta; Ranjan Malhotra; James Peace; Bridgitte Shen Lee; Brittany Mitchell; Kenneth Sall; Matthew McMenemy
Journal:  Eye Contact Lens       Date:  2022-04-01       Impact factor: 2.018

10.  Cytokine and Growth Factor Analysis in Exfoliation Syndrome and Glaucoma.

Authors:  Do Young Park; Moohyun Kim; Soon Cheol Cha
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.